Carmen Mikacenic

机构：University of Washington, Mercedes-Benz Research and Development North America (United States), Washington Research Foundation, Benaroya Research Institute · ORCID：0000-0001-8966-5161

发表论文 110 篇 · 总被引 5665 次 · h-index 30

代表论文

• Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia (2023 · EBioMedicine · 被引 20)
• Urinary proteomics identifies distinct immunological profiles of sepsis associated AKI sub-phenotypes (2024 · Critical Care · 被引 17)
• The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure (2023 · Nature Communications · 被引 16)
• PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome (2024 · American Journal of Respiratory Cell and Molecular Biology · 被引 13)
• Single-cell transcriptomic profiling of eosinophils and airway immune cells in childhood asthma (2025 · Journal of Allergy and Clinical Immunology · 被引 9)
• A ventilated perfused lung model platform to dissect the response of the lungs to viral infection (2025 · Trends in biotechnology · 被引 4)